New Key Statistics Module, Z-Score and F-Score
NAS:RPTX Key Ratios
| Market Cap $ M | 141.14 |
| Enterprise Value $ M | -35.73 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.81 |
| Price/Sales | 2.18 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 66.00 |
| EPS (TTM) $ | -2.00 |
| Beneish M-Score | -2.99 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -10.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.39 |
| EV-to-EBITDA | 0.40 |
| PEG | -- |
| Shares Outstanding M | 42.51 |
| Net Margin (%) | -126.34 |
| Operating Margin % | -138.62 |
| Pre-tax Margin (%) | -123.89 |
| Quick Ratio | 6.45 |
| Current Ratio | 6.45 |
| ROA % (ttm) | -33.75 |
| ROE % (ttm) | -39.79 |
| ROIC % (ttm) | -423.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.04 |
RPTX Number of Guru Trades
RPTX Volume of Guru Trades
Gurus Latest Trades with NAS:RPTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Repare Therapeutics Inc Insider Transactions
No Available Data
News about NAS:RPTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers